Clinical Trials Logo

Muscle Hypotonia clinical trials

View clinical trials related to Muscle Hypotonia.

Filter by:

NCT ID: NCT06060197 Recruiting - Clinical trials for Allan-Herndon-Dudley Syndrome

MCT8 Deficiency Caregiver Study

Start date: August 23, 2022
Phase:
Study type: Observational

Caregivers face many responsibilities outside of their role as a friend or parent, which can lead to emotional, financial, social, and professional challenges. To better understand the impact of MCT8 deficiency on caregivers, Egetis Therapeutics are conducting an online survey for adult caregivers of persons living with the MCT8 deficiency.

NCT ID: NCT05911399 Available - Clinical trials for Allan-Herndon-Dudley Syndrome

Expanded Access Program for Tiratricol in Patients With Monocarboxylate Transporter 8 Deficiency

Start date: n/a
Phase:
Study type: Expanded Access

The goal of this program is to provide expanded access (i.e., before marketing authorization) to tiratricol as treatment for patients with monocarboxylate transporter 8 deficiency (MCT8 deficiency, also known as Allan-Herndon-Dudley syndrome [AHDS]), who in their Treating Physician's opinion, could benefit from tiratricol and meet the eligibility criteria.

NCT ID: NCT05716256 Not yet recruiting - Clinical trials for Nondepolarising Muscle Relaxants

Effect of Ulinastatin on the Action of NDMRs (Rocuronium / Cisatracurium)

Start date: February 15, 2023
Phase: N/A
Study type: Interventional

The aim of this research was to determine the influence of ulinastatin on nondepolarising muscle relaxants Rocuronium and Cisatracurium.

NCT ID: NCT05579327 Recruiting - Clinical trials for Allan-Herndon-Dudley Syndrome

Withdrawal of Tiratricol Treatment in Males With Monocarboxylate Transporter 8 Deficiency (MCT8 Deficiency)

ReTRIACt
Start date: July 21, 2023
Phase: Phase 3
Study type: Interventional

This is a double-blind, randomized phase 3 multicenter placebo-controlled study in at least 16 evaluable male participants diagnosed with MCT8 deficiency. Male participants, from 4 years of age (at randomization) and having demonstrated stable maintenance treatment with tiratricol, will be randomized to receive placebo or tiratricol for 30 days or until reaching rescue criterion (serum total triiodothyronine [T3] > upper limit of normal [ULN] of the participant's normal range, for a sample collected during the 30-day Randomized Treatment Period). The research hypothesis to be tested is that, for participants in the placebo group, removal of tiratricol will lead to an increase of serum total T3 concentration, measured by liquid chromatography with tandem mass spectrometry (LC/MS/MS), above the ULN and requirement of rescue treatment with tiratricol, compared to those who continue to receive tiratricol.

NCT ID: NCT05527652 Recruiting - Clinical trials for Obstructive Sleep Apnea

Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia

Start date: November 16, 2022
Phase: N/A
Study type: Interventional

The researchers are investigating if the Self-Supporting Nasopharyngeal Airway (ssNPA) device can be used in the treatment of obstructive sleep apnea in children with Hypotonic Upper Airway Obstruction (HUAO).

NCT ID: NCT05521217 Enrolling by invitation - Clinical trials for Spinal Muscular Atrophy

Myotonometer Intra- and Inter Examiner Reliability on Spinal Muscular Atrophy

Start date: August 26, 2022
Phase:
Study type: Observational

The primary aim of the study was to measure the intra-rater and inter-rater reliability of MyotonPRO in measuring postural muscle tone and mechanical properties in individuals with spinal muscular atrophy (SMA). The secondary aim is to question the existence of a relationship between the functional levels of individuals with SMA and their muscle tone and biomechanical properties. It is assumed that the outputs to be obtained from this research will form the norm data for moyotonometer evaluation in children with SMA.

NCT ID: NCT05440058 Completed - Anesthesia Clinical Trials

BIS Monitoring in Relation to Muscle Relaxant Administration

Start date: August 26, 2022
Phase:
Study type: Observational

The purpose of this study is to determine the overall optimal timing of when the Bispectral Index (BIS) monitor should be started: before or after the muscle relaxant is given.

NCT ID: NCT05432570 Completed - Clinical trials for Intubation; Difficult or Failed

Use of Muscle Relaxants in Parotidectomy Operation With Neuromonitoring

Start date: June 30, 2022
Phase: N/A
Study type: Interventional

Neuromuscular blockers provide muscle relaxation by blocking the electrical conduction to motor nerves and facilitate endotracheal tube placement while relaxing the whole body for surgical comfort during general anesthesia. Parotid surgery is a procedure performed by ear, nose and throat physicians, and as a complication during this procedure, permanent facial paralysis may develop due to damage to the facial nerve. Intraoperative nerve monitoring is frequently used to avoid this complication. The application of local anesthetic to the vocal cords and into the trachea has been tried and found useful for induction of anesthesia without the use of neuromuscular blockers. In studies conducted with this technique, a standard local anesthetic dose was not specified and local anesthetics were generally administered alone and in high doses. It is expected that anesthesia induction and intubation without the use of muscle relaxants will not affect the comfort of the patient and the procedure, but will increase the surgical time and surgical satisfaction.

NCT ID: NCT05391594 Completed - Cerebral Palsy Clinical Trials

Effect of Trunk Support on Academic Engagement of Children With Severe Disability

Start date: May 31, 2018
Phase: N/A
Study type: Interventional

This study evaluates the effect of optimizing trunk support based on segmental principles of trunk control, on academic engagement of children in academic settings.

NCT ID: NCT05310110 Completed - Anesthesia, General Clinical Trials

Muscle Relaxants and Laryngeal Local Anesthetics for Laryngeal Mask Airway Insertion Decreasing Propofol in Elderly

LMA
Start date: April 12, 2022
Phase: N/A
Study type: Interventional

Laryngeal mask airway (LMA) is currently the most widely used supraglottic airway device with advantages of simple and fast placement, reduced anesthesia drug use, more stable hemodynamics, and less throat discomfort after anesthesia compared to endotracheal intubation. Some studies claimed the use of muscle relaxants or local anesthetics (sprays or lubricants containing local anesthetics) for the throat before LMA placement can reduce the dosage of induction agents and postoperative throat complications. In modern society, more and more elderly people undergo elective surgery with the need of general anesthesia. However, they are the more vulnerable population with tendency of greater hemodynamic changes with more induction agent usage. Propofol is one of the most used induction agents which may lead to a drop in blood pressure. The objective of this study is to observe whether the dose of propofol and the changes in hemodynamics can be reduced by using muscle relaxants or laryngeal local anesthetics in elderly who receiving general anesthesia with LMA insertion.